Revvity | PKI - 贸易债权人



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 14.21B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


贸易债权人 更改 日
Agilent USD 615M 13M 2026-03
Align Technology USD 109.84M 13.88M 2026-06
Bio Techne USD 95.6M 3.97M 2026-03
Bio-Rad Laboratories USD 143.5M 10.4M 2026-06
Bruker USD 200.2M 68.9M 2026-06
Celltrion KRW 88.58B 9.9B 2026-03
Charles River Laboratories USD 140.98M 7.03M 2026-06
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Danaher USD 2.07B 282M 2026-06
Dentsply International USD 260M 1000K 2026-06
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 6.39M 1.12M 2026-06
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Edwards Lifesciences USD 210.5M 29.4M 2026-06
Illumina USD 230M 12M 2026-06
Intuitive Surgical USD 1.92B 66.6M 2026-06
IQVIA Holdings USD 3.61B 31M 2026-06
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Laboratory Of America USD 688.5M 7.2M 2026-06
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Mesa Laboratories USD 5.25M 163K 2025-12
Mettler Toledo International USD 229.8M 1.08M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
OraSure Technologies USD 8.4M 2.23M 2026-06
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pacific Biosciences Of California USD 19.22M 5.61M 2026-06
Pharma Mar EUR 38.93M 4.9M 2026-06
Qiagen NV USD 79.08M 785K 2026-06
Quest Diagnostics USD 1.6B 98M 2026-06
Quidel USD 236.5M 7M 2026-06
Repligen USD 33.23M 1.42M 2026-06
Revvity USD 165.74M 3.94M 2026-06
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Waters USD 602M 498.22M 2026-03
Zealand Pharma A/S 171M 175.6M 2026-03
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03